CoChat

Melatonin: Clinical Perspectives in Neurodegeneration

Open access
Cardinali, Daniel P. · 2019 · Frontiers in Endocrinology
Cited by 197

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) are important health problems and there is a growing recognition that both governmental and non-governmental organizations must make efforts to prevent, in addition to treat, them. In this context, the pineal product melatonin has a promising significance. Melatonin, an unusual phylogenetically conserved molecule present in all known aerobic organisms, is effective both as a chronobiotic and as a cytoprotective. As a chronobiotic, the afternoon increase in melatonin "opens the doors of sleep" every night and the therapeutic use of melatonin has been demonstrated to preserve slow wave sleep effectively. As a cytoprotective molecule, melatonin reverses the low degree inflammatory damage seen in neurodegenerative disorders and ageing. One of the characteristics of advancing age is the gradual decrease in the circulating levels of melatonin. Both in vitro and in vivo, melatonin prevented the neurodegeneration observed in experimental models of AD and PD. Melatonin also increased removal of toxic proteins by the brain glymphatic system. A limited number of clinical trials have indicated that melatonin has a potential therapeutic value as a neuroprotective drug in the treatment of AD, particularly at an early stage of cognitive impairment, and of PD. From animal studies the cytoprotective effects of melatonin need high doses to become apparent (i.e. in the 40-100 mg/day range). The off-label use of melatonin is discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fendo.2019.00480

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 197

Metadata

Authors
Cardinali, D. P.
Venue
Frontiers in Endocrinology
Published
2019-07-16
Volume
10
Pages
480-480
ISSN
1664-2392 (ISSN-L)
OpenAlex
W2960257281
Cited by
197
References
19
FWCI
12.24
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Melatonin: Clinical Perspectives in Neurodegeneration. https://app.cochat.ai/papers/10.3389/fendo.2019.00480
The paper
Cardinali, D. P. (2019). Melatonin: Clinical Perspectives in Neurodegeneration. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2019.00480

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.